Home › Products › Infectious Disease › Hepcinat Plus Tablet
Hepcinat Plus Tablet
Salt Composition: SOFOSBUVIR,DACLASTAVIR
- Manufacturer: MYLAN PHARMACEUTICALS PVT LTD
- Pack Size: 28 TABLET(s) IN A STRIP
- Dosage Form: TABLET
- Strength: 400MG+60MG
- Prescription Required
- Storage: Store at temprature between 20-25°C (68-77°F). Keep away from moisture, heat, and light. It should not be frozen. Keep it in its original packaging until it is ready to be used. Keep out of the reach of children and pets.
₹6871.00₹16359.38
Inclusive of all taxes
Product Introduction
Hepcinat Plus contains the active agents daclatasvir and sofosbuvir. It is an antiviral medication used to treat chronic hepatitis C virus (HCV) infections. Hepatitis C infection is a liver disease caused by the hepatitis C virus (HCV). Inform your doctor if you have liver problems other than hepatitis C infection, have had a liver transplant, have diabetes, heart disorders, severe kidney problems, or are on dialysis before taking Hepcinat Plus. Your doctor will perform blood tests to check for hepatitis B virus infection before starting treatment with this medicine, as this medicine can reactivate the hepatitis B virus. Hepatitis B virus reactivation can cause serious liver problems and liver failure. It is important to inform your doctor if you are taking or have taken any medication for heart problems in the past months. Elderly patients may be more susceptible to the side effects of Hepcinat Plus and may require lower doses or closer monitoring during treatment. The safety and effectiveness in paediatric patients have not been established. This medication should only be used in children under the guidance of a paediatric specialist.
Uses
Treatment of chronic hepatitis C virus (HCV) infection
How it works
Daclatasvir is a direct-acting antiviral medication that works by inhibiting a protein called NS5A, which is essential for the replication of the hepatitis C virus. Sofosbuvir is another direct-acting antiviral medication that works by inhibiting a different protein called NS5B, which is also essential for the replication of the hepatitis C virus. These are used to increase its effectiveness in treating HCV.
How to Use
Take Hepcinat plus tablet exactly as prescribed by your doctor. The recommended dose and dosing schedule may vary depending on your medical condition, age, weight, and other factors. It should be taken with food. Swallow the tablet as a whole with a glass of water. Patients should not chew, crush, or break the tablet, as this may affect the effectiveness of the medication. Avoid doubling the dose to compensate for the missed dose.
Side Effects
Hepcinat plus tablet cause some side effects like all medications, although not everyone will experience them. Serious: Liver problems (such as elevated liver enzymes or liver failure) Allergic reactions (such as rash or difficulty breathing) Abnormal heart rhythms Common: Headache Fatigue Nausea Diarrhea Difficulty sleeping
Expert Tips
If you have been prescribed Hepcinat plus tablet, it is important to follow your doctor's instructions carefully. Suppose you experience any unusual symptoms or side effects while taking this medicine, such as fever, persistent cough, difficulty breathing, abdominal pain, or signs of liver dysfunction. In such a case, you should contact your doctor immediately. Do not stop medication without first consulting your doctor, as this may affect the effectiveness of the medication and your treatment outcomes. Pregnant and breastfeeding women should consult with a healthcare provider before taking it. Special caution should be taken when this medication is used in the elderly and pediatrics. Avoid close contact with an infected person, as this medication lowers the immune system. Always maintain a healthy and balanced diet to support your overall health and well-being.
References
- Bristol-Myers Squibb Company, US Food and Drug Administration, [Revised on Feb 2017] [Accessed on 12th May 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/206843s006lbl.pdf
- Gilead Sciences Ireland UC, European Medical Agency (ema), [Revised on Sept 2018] [ Accessed on 12th May 2023], https://www.ema.europa.eu/en/documents/product-information/sovaldi-epar-product-information_en.pdf
- Gilead Sciences, US Food, and Drug Administration, [ Revised on August 2015] [ Accessed on 12th May 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204671s002lbl.pdf
Safety Advice
Pregnancy: Consult your doctor The safety of Hepcinat plus tablet during pregnancy is not well-established. Pregnant women should consult their healthcare provider about their pregnancy status before receiving this medication.
Lungs: Consult your doctor Patients should consult a healthcare provider with any pre-existing lung conditions with their healthcare provider before starting treatment with Hepcinat plus tablet.
Breastfeeding: Consult your doctor It is unknown if Hepcinat plus tablet is excreted in human breast milk, so breastfeeding women should consult a healthcare provider before taking this medication.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.